Ligand Pharmaceuticals
LGND
LGND
242 hedge funds and large institutions have $1.81B invested in Ligand Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 98 increasing their positions, 53 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 233 → 242 (+9)
3.16% more ownership
Funds ownership: 96.02% → 99.18% (+3.2%)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
242
Holding in Top 10
2
Calls
$5.91M
Puts
$931K
Top Buyers
| 1 | +$12.9M | |
| 2 | +$11.9M | |
| 3 | +$11.5M | |
| 4 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$10.1M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$9.64M |
Top Sellers
| 1 | -$7.98M | |
| 2 | -$7.16M | |
| 3 | -$3.35M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.75M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.21M |